We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Medicine for Apollo?

16 November 2009 By Lauren Silva

The largest US pension fund is bothered by the fees it has paid Apollo. It has already endorsed calls for lower fees and giving investors in private equity more say. If Calpers does put the screws on Apollo, other big investors and other buyout firms won’t be far behind.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)